embelin has been researched along with malondialdehyde in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Abraham, A; Joy, B; Kumar, SN; Radhika, AR | 1 |
Bhandari, S; Deshmukh, R; Mishra, N; Sharma, N; Yadav, AK | 1 |
Cui, P; Gubbiyappa, SK; Mishra, A; Qu, F; Sharma, S; Sreeharsha, N | 1 |
3 other study(ies) available for embelin and malondialdehyde
Article | Year |
---|---|
Embelin (2,5-Dihydroxy-3-undecyl-p-benzoquinone) for photodynamic therapy: study of their cytotoxicity in cancer cells.
Topics: Animals; Benzoquinones; Carcinoma, Ehrlich Tumor; Male; Malondialdehyde; Mice; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species | 2015 |
Development and characterization of embelin-loaded nanolipid carriers for brain targeting.
Topics: Administration, Intranasal; Animals; Benzoquinones; Brain; Convulsants; Drug Carriers; Drug Compounding; Drug Liberation; Female; Glutathione; Male; Malondialdehyde; Nanoparticles; Nitrites; Palmitates; Particle Size; Pentylenetetrazole; Poloxamer; Rats; Rats, Wistar; Tissue Distribution | 2017 |
Antiarthritic effect of chitosan nanoparticle loaded with embelin against adjuvant-induced arthritis in Wistar rats.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Benzoquinones; Chitosan; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Carriers; Drug Compounding; Freund's Adjuvant; Gene Expression Regulation; Hindlimb; Interleukin-1beta; Interleukin-6; Male; Malondialdehyde; Nanoparticles; NF-kappa B; Nitric Oxide; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2020 |